Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Oric Pharmaceuticals is a biopharmaceutical company focused on developing therapies that overcome resistance in cancer. Its pipeline includes targeted treatments for hormone-dependent cancers, precision oncology, and tumor dependencies, with a focus on resistant solid tumors like lung and prostate cancers. The company leverages biomarker-driven approaches, internal discovery capabilities, and strategic collaborations to deliver innovative, targeted cancer therapies.
This description was generated via AI from an annual report. Updated about 1 year ago.